Form 4: Aspira Women's Health Director, Ellen O'Connor Vos, Reports Acquisition of Restricted Stock Units

Director Ellen O'Connor Vos reports acquisition of restricted stock units in Aspira Women's Health, which vested on August 12, 2024.

Summary

• On August 12, 2024, Ellen O'Connor Vos, a director of Aspira Women's Health Inc., acquired 16,593 shares of common stock.
• These shares were obtained through the vesting of restricted stock units (RSUs).
• The RSUs vested fully on August 12, 2024, and each RSU represents the right to receive one share of Aspira Women's Health Inc. common stock.
• Following the transaction, Vos directly owns 52,739 shares of Aspira Women's Health Inc.

Sentiment

Score: 6

Explanation: The sentiment is neutral as it reflects a standard transaction related to executive compensation. It doesn't inherently indicate positive or negative performance for the company.

Positives

• The director's acquisition of shares through RSU vesting could be seen as a positive signal, indicating confidence in the company's future performance.

Industry Context

Form 4 filings are standard practice and provide transparency into the transactions of company insiders, allowing investors to track ownership changes and potential alignment of interests.

Stakeholder Impact

• The transaction provides transparency to shareholders regarding insider ownership.

Key Dates

Keywords

Aspira Women's Health, Director, Form 4, Beneficial Ownership, Restricted Stock Units, AWH, Vesting